Compound Detail
CHEMBL525803
CHLOROPEPTIN Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CN1C(=O)[C@@H](c2cc(Cl)c(O)c(Cl)c2)NC(=O)[C@@H]2NC(=O)[C@@H](c3cc(Cl)c(O)c(Cl)c3)NC(=O)[C@H](NC(=O)C(=O)c3cc(Cl)c(O)c(Cl)c3)Cc3c[nH]c4c(cccc34)-c3cc2cc(c3O)Oc2ccc(cc2)C[C@H]1C(=O)N[C@@H](C(=O)O)c1ccc(O)cc1
Basic Information
| ChEMBL ID | CHEMBL525803 |
| Name | CHLOROPEPTIN |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | FRRCHJPQSWYJSH-OZICGBTHSA-N |
4
Targets
8
Activities
1
Assay Types
0
PK Parameters
8
Publications
0
Known Names
Molecular Properties
1328.8
MW (Da)
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 8 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 8.0 | 6.155 | 10.0 | 4 |
| T-cell surface glycoprotein CD4 CHEMBL2754 | IC50 | 6.89 | 6.89 | 130.0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI CHEMBL3994 | IC50 | 6.52 | 6.52 | 300.0 | 1 |
| Human immunodeficiency virus type 1 integrase CHEMBL3471 | IC50 | 6.4 | 5.85 | 400.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 12565974 | 10.1016/s0960-894x(02)00919-8 | Unchecked | 2 |
| 15026053 | 10.1016/j.bmcl.2004.01.056 | Unchecked | 2 |
| 11473415 | 10.1021/np000632z | Human immunodeficiency virus type 1 integrase | 2 |
| 12565974 | 10.1016/s0960-894x(02)00919-8 | T-cell surface glycoprotein CD4 | 1 |
| 11473415 | 10.1021/np000632z | Human immunodeficiency virus 1 | 1 |
| 19786602 | 10.1128/aac.00670-09 | Unchecked | 1 |
| 32883635 | 10.1016/j.ejmech.2020.112757 | Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI | 1 |
| 32883635 | 10.1016/j.ejmech.2020.112757 | Staphylococcus aureus | 1 |
Data from ChEMBL 36 via Core Engine